SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Matinas BioPharma Hldgs Q1 EPS $(0.03), Inline, Sales $33.33K Beat $20.00K Estimate

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of

05/10/2021 06:32
Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $33.33 thousand which beat the analyst consensus estimate of $20.00 thousand by 66.65 percent.